Key result
Thoracic radiotherapy is linked to ~137% higher cardiovascular death risk versus the general population.
Why the study?
Cardiotoxicity following thoracic radiotherapy remains a critical issue, motivating an assessment of cardiovascular-related death risk and comparison across different cancer sites.
Does thoracic radiotherapy increase the risk of cardiovascular-related death in patients with thoracic cancers compared to the general population, and does the risk vary by tumor site?
Does thoracic radiotherapy increase the risk of cardiovascular-related death in patients with thoracic cancers compared to the general population, and does the risk vary by tumor site?
Thoracic radiotherapy significantly increases the risk of cardiovascular-related death, particularly for left-sided and lower lung tumors, highlighting the need for targeted cardiovascular monitoring in this population.
May warrant enhanced CV monitoring after thoracic RT; challenges consensus on uniform risk and leaves open causal confirmation in trials.
Cardiotoxicity following thoracic radiotherapy remains a critical issue, and this study aimed to assess the risk of Cardiovascular-Related Death (CVRD) after thoracic radiotherapy while comparing the risk of CVRD at different cancer sites. Data on patients with thoracic cancers treated with radiotherapy between 2000 and 2020 were analyzed, and the risk of CVRD was evaluated using death rates, Fine-Gray competing risks model, standardized mortality ratio (SMR), absolute excess risk (AER), and Cox regression to develop a predictive model. Patients receiving radiotherapy for thoracic cancer had a significantly increased risk of CVRD compared with the general population (Overall AER = 28.59, SMR = 2.37, 95% CI: 2.33–2.40). The risk of CVRD after radiotherapy was significantly lower in the right chest than the left (HR = 0.84, 95% CI: 0.79–0.89) and significantly higher in the left lower lung than in the upper (HR = 1.11, 95% CI: 1.01–1.22). A predictive model for the risk of CVRD in patients with left lower lung after radiotherapy was further constructed (C-index = 0.67, 95% CI: 0.67–0.68). The findings highlight that thoracic radiotherapy significantly increases cardiovascular disease risk, with patients with left lower lung cancer exhibiting the highest CVRD risk. A robust predictive model was developed, offering valuable insights for managing and predicting CVRD risk in thoracic malignancies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question. Patients receiving thoracic radiotherapy had a 2.37-fold increased risk of cardiovascular-related death compared to the general population, with significant site-specific variations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: